Ossendorp F - Search Results

1

Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells.

Khan S, Weterings JJ, Britten CM, de Jong AR, Graafland D, Melief CJ, van der Burg SH, van der Marel G, Overkleeft HS, Filippov DV, Ossendorp F. Khan S, et al. Among authors: ossendorp f. Mol Immunol. 2009 Mar;46(6):1084-91. doi: 10.1016/j.molimm.2008.10.006. Epub 2008 Nov 22. Mol Immunol. 2009. PMID: 19027958

We have recently explored the cellular mechanisms underlying the efficient induction of a CD8(+) cytotoxic T lymphocyte response by such synthetic model vaccines [Khan, S., Bijker, M.S., Weterings, J.J., Tanke, H.J., Adema, G.J., van, H.T., Drijfhout, J.W., Melief, C.J., Overklee …

We have recently explored the cellular mechanisms underlying the efficient induction of a CD8(+) cytotoxic T lymphocyte response by such syn …

2

T cell depletion in transgenic mice carrying a mutant gene for TCR-beta.

Krimpenfort P, Ossendorp F, Borst J, Melief C, Berns A. Krimpenfort P, et al. Among authors: ossendorp f. Nature. 1989 Oct 26;341(6244):742-6. doi: 10.1038/341742a0. Nature. 1989. PMID: 2552327

3

Production of monoclonal antibodies to thyroglobulin by in vitro immunization with a free synthetic peptide.

de Boer M, Ossendorp FA, Al BJ, Hilgers J, de Vijlder JJ, Tager JM. de Boer M, et al. Among authors: ossendorp fa. Mol Immunol. 1987 Oct;24(10):1081-6. doi: 10.1016/0161-5890(87)90076-9. Mol Immunol. 1987. PMID: 3683404

4

Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice.

Sijts AJ, De Bruijn ML, Ressing ME, Nieland JD, Mengedé EA, Boog CJ, Ossendorp F, Kast WM, Melief CJ. Sijts AJ, et al. Among authors: ossendorp f. J Virol. 1994 Sep;68(9):6038-46. doi: 10.1128/JVI.68.9.6038-6046.1994. J Virol. 1994. PMID: 7520098 Free PMC article.

5

Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences.

Neisig A, Roelse J, Sijts AJ, Ossendorp F, Feltkamp MC, Kast WM, Melief CJ, Neefjes JJ. Neisig A, et al. Among authors: ossendorp f. J Immunol. 1995 Feb 1;154(3):1273-9. J Immunol. 1995. PMID: 7822796

6

Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.

Sijts AJ, Ossendorp F, Mengedé EA, van den Elsen PJ, Melief CJ. Sijts AJ, et al. Among authors: ossendorp f. J Immunol. 1994 Jan 1;152(1):106-16. J Immunol. 1994. PMID: 8254184

7

Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization.

Feltkamp MC, Vierboom MP, Toes RE, Ossendorp F, ter Schegget J, Melief CJ, Kast WM. Feltkamp MC, et al. Among authors: ossendorp f. Immunol Lett. 1995 Jul-Aug;47(1-2):1-8. doi: 10.1016/0165-2478(95)00052-7. Immunol Lett. 1995. PMID: 8537084

8

A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.

Ossendorp F, Eggers M, Neisig A, Ruppert T, Groettrup M, Sijts A, Mengedë E, Kloetzel PM, Neefjes J, Koszinowski U, Melief C. Ossendorp F, et al. Immunity. 1996 Aug;5(2):115-24. doi: 10.1016/s1074-7613(00)80488-4. Immunity. 1996. PMID: 8769475 Free article.

9

Lysis of syngeneic tumor B cells by autoreactive cytotoxic T lymphocytes specific for a CD19 antigen-derived synthetic peptide.

Hooijberg E, Visseren MJ, van den Berk PC, Jellema AP, Romeijn P, Sein JJ, van der Voort EI, Hekman A, Ossendorp F, Melief CJ. Hooijberg E, et al. Among authors: ossendorp f. J Immunother Emphasis Tumor Immunol. 1996 Sep;19(5):346-56. doi: 10.1097/00002371-199609000-00004. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8941874

10

Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity.

Ressing ME, Offringa R, Toes RE, Ossendorp F, de Jong JH, Brandt RM, Kast WM, Melief CJ. Ressing ME, et al. Among authors: ossendorp f. Immunotechnology. 1996 Nov;2(4):241-51. doi: 10.1016/s1380-2933(96)00057-7. Immunotechnology. 1996. PMID: 9373306 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters